| NDC Code | 68462-329-01 |
|---|
| Package Description | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-329-01) |
|---|
| Product NDC | 68462-329 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Trandolapril And Verapamil Hydrochloride |
|---|
| Non-Proprietary Name | Trandolapril And Verapamil Hydrochloride |
|---|
| Dosage Form | TABLET, FILM COATED, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20150225 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA079135 |
|---|
| Manufacturer | Glenmark Pharmaceuticals Inc., USA |
|---|
| Substance Name | TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE |
|---|
| Strength | 4; 240 |
|---|
| Strength Unit | mg/1; mg/1 |
|---|
| Pharmacy Classes | Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA] |
|---|